help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on October 9, 2003, doi:10.1164/rccm.200305-640OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200305-640OCv1
169/1/83    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suissa, S.
Right arrow Articles by Ernst, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suissa, S.
Right arrow Articles by Ernst, P.
American Journal of Respiratory and Critical Care Medicine Vol 169. pp. 83-88, (2004)
© 2004 American Thoracic Society

Inhaled and Nasal Corticosteroid Use and the Risk of Fracture

Samy Suissa, Marc Baltzan, Richard Kremer and Pierre Ernst

Divisions of Clinical Epidemiology and Endocrinology, Royal Victoria Hospital, McGill University Health Centre; Department of Epidemiology and Biostatistics and of Medicine, McGill University; Department of Respiratory Medicine, Mount Sinai Hospital; and Division of Respiratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada

Correspondence and requests for reprints should be addressed to Samy Suissa, Ph.D., Division of Clinical Epidemiology, Royal Victoria Hospital, 687 Pine Avenue West, Ross 4.29, Montreal, PQ, H3A 1A1 Canada. E-mail: samy.suissa{at}clinepi.mcgill.ca

Studies of the risk of fracture associated with inhaled corticosteroids are inconclusive and are limited to short-term effects. We assessed whether long-term use increases this risk. We conducted a case control study nested within a population-based cohort of all Quebec elderly dispensed respiratory medications and followed for at least 4 years during 1988–2001. There were 9,624 new cases of fracture of the hip or upper extremities and 191,622 age-matched control subjects (mean age of 81 years). The rate of any such fracture for current inhaled corticosteroid use was not elevated (rate ratio [RR], 0.97; 95% confidence interval [CI], 0.92–1.03). For upper-extremity fracture, the rate increased by 12% (RR, 1.12; 95% CI, 1.04–1.19) with every 1,000-µg increase in the daily dose of inhaled corticosteroids, but not for hip fracture (RR, 0.97; 95% CI, 0.88–1.07). Among subjects followed for over 8 years, the rate of hip fracture was only elevated with daily doses of more than 2,000 µg of inhaled corticosteroids (RR, 1.61; 95% CI, 1.04–2.50). The rate was not elevated at any dose of nasal corticosteroids. In conclusion, the long-term use of inhaled and nasal corticosteroids at the usual recommended doses is not associated with a risk of fracture in older patients with respiratory disease.

Key Words: asthma • cohort studies • chronic obstructive pulmonary disease • glucocorticoids • osteoporosis




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Suissa
Medications to Modify Lung Function Decline in Chronic Obstructive Pulmonary Disease: Some Hopeful Signs
Am. J. Respir. Crit. Care Med., August 15, 2008; 178(4): 322 - 323.
[Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
W. M. Chatila, B. M. Thomashow, O. A. Minai, G. J. Criner, and B. J. Make
Comorbidities in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2008; 5(4): 549 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. Suissa, R. McGhan, D. Niewoehner, and B. Make
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, October 1, 2007; 4(7): 535 - 542.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
M. Pujades-Rodriguez, C.J.P. Smith, and R.B. Hubbard
Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease
QJM, August 1, 2007; 100(8): 509 - 517.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Ernst, A. V. Gonzalez, P. Brassard, and S. Suissa
Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease and the Risk of Hospitalization for Pneumonia
Am. J. Respir. Crit. Care Med., July 15, 2007; 176(2): 162 - 166.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
P. Ernst, A. McIvor, F. M. Ducharme, L.-P. Boulet, M. FitzGerald, K. R. Chapman, T. Bai, and for the Canadian Asthma Guideline Group
Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids.
Ann Intern Med, November 7, 2006; 145(9): 692 - 694.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
J. Glassroth
Use of long-acting beta-agonists and inhaled corticosteroids.
Ann Intern Med, November 7, 2006; 145(9): 710 - 710.
[Full Text] [PDF]

Home page
 ChestHome page
R. Hubbard, A. Tattersfield, C. Smith, J. West, L. Smeeth, and A. Fletcher
Use of inhaled corticosteroids and the risk of fracture.
Chest, October 1, 2006; 130(4): 1082 - 1088.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
F. de Vries, T. P. van Staa, M. S. G. M. Bracke, C. Cooper, H. G. M. Leufkens, and J-W. J. Lammers
Severity of obstructive airway disease and risk of osteoporotic fracture
Eur. Respir. J., May 1, 2005; 25(5): 879 - 884.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 686 - 698.
[Full Text] [PDF]

Home page
 ChestHome page
C. B. Johannes, G. A. Schneider, T. J. Dube, T. D. Alfredson, K. J. Davis, and A. M. Walker
The Risk of Nonvertebral Fracture Related to Inhaled Corticosteroid Exposure Among Adults With Chronic Respiratory Disease
Chest, January 1, 2005; 127(1): 89 - 97.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. D. Scanlon, J. E. Connett, R. A. Wise, D. P. Tashkin, T. Madhok, M. Skeans, P. C. Carpenter, W. C. Bailey, A. S. Buist, M. Eichenhorn, et al.
Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1302 - 1309.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. E. Tattersfield, T. W. Harrison, R. B. Hubbard, and K. Mortimer
Safety of Inhaled Corticosteroids
Proceedings of the ATS, November 1, 2004; 1(3): 171 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Suissa, P. Ernst, T. A. Lee, and K. B. Weiss
Inhaled Corticosteroids and Fracture Risk in COPD
Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 94 - 95.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. A. Lee and K. B. Weiss
Fracture Risk Associated with Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 855 - 859.
[Abstract] [Full Text] [PDF]

Home page
 JWatch GeneralHome page
Are Inhaled or Nasal Steroids Associated with Fractures?
Journal Watch (General), February 3, 2004; 2004(203): 3 - 3.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2004 American Thoracic Society